1.095
price down icon12.75%   -0.16
after-market Dopo l'orario di chiusura: 1.15 0.055 +5.02%
loading
Precedente Chiudi:
$1.255
Aprire:
$1.14
Volume 24 ore:
427.50K
Relative Volume:
0.16
Capitalizzazione di mercato:
$35.80M
Reddito:
-
Utile/perdita netta:
$-87.23M
Rapporto P/E:
-0.3687
EPS:
-2.97
Flusso di cassa netto:
$-82.77M
1 W Prestazione:
-26.01%
1M Prestazione:
-51.97%
6M Prestazione:
-88.23%
1 anno Prestazione:
-90.55%
Intervallo 1D:
Value
$1.04
$1.155
Intervallo di 1 settimana:
Value
$1.04
$1.50
Portata 52W:
Value
$1.04
$19.30

Pepgen Inc Stock (PEPG) Company Profile

Name
Nome
Pepgen Inc
Name
Telefono
703-456-8000
Name
Indirizzo
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Name
Dipendente
81
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-08
Name
Ultimi documenti SEC
Name
PEPG's Discussions on Twitter

Confronta PEPG con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PEPG
Pepgen Inc
1.095 35.80M 0 -87.23M -82.77M -2.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Pepgen Inc Stock (PEPG) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-16 Downgrade BofA Securities Neutral → Underperform
2024-07-31 Downgrade BofA Securities Buy → Neutral
2022-12-21 Iniziato H.C. Wainwright Buy

Pepgen Inc Borsa (PEPG) Ultime notizie

pulisher
06:46 AM

PepGen (NASDAQ:PEPG) Stock Price Down 14.4% – Time to Sell? - Defense World

06:46 AM
pulisher
Apr 02, 2025

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference - BioSpace

Apr 02, 2025
pulisher
Apr 01, 2025

PepGen Announces Appointment of Two New Directors to its Board - BioSpace

Apr 01, 2025
pulisher
Mar 31, 2025

PepGen Inc. Expands Board with New Appointments - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

PepGen names two new directors to board - TipRanks

Mar 31, 2025
pulisher
Mar 28, 2025

PepGen CMO Mellion resigns, effective April 4 By Investing.com - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

PepGen CMO Mellion resigns, effective April 4 - Investing.com

Mar 28, 2025
pulisher
Mar 26, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen IncPEPG - Bluefield Daily Telegraph

Mar 26, 2025
pulisher
Mar 18, 2025

PEPG ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of PepGen Inc. Shareholders Who Lost Money - ACCESS Newswire

Mar 18, 2025
pulisher
Mar 10, 2025

PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference - Business Wire

Mar 10, 2025
pulisher
Mar 10, 2025

PepGen Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsPEPG - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 05, 2025

PepGen Inc. Faces Clinical Trial Challenges and Competitive Pressures Leading to Sell Rating - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

What Do Analysts Think Will Happen To PepGen Inc (NASDAQ: PEPG) - Stocks Register

Mar 05, 2025
pulisher
Mar 05, 2025

PepGen pauses Phase II DMD trial to review safety data - Clinical Trials Arena

Mar 05, 2025
pulisher
Mar 04, 2025

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls - Benzinga

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Boston biotech's stock drops after Duchenne trial pause - The Business Journals

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen to pause CONNECT2-EDO51 study - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen slumps after pausing mid-stage study of Duchenne drug - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen pauses phase 2 DMD study to review earlier trial data - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD -March 04, 2025 at 08:18 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen stock slides after trial pause (PEPG:NASDAQ) - Seeking Alpha

Mar 04, 2025
pulisher
Mar 04, 2025

Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen to Participate in Upcoming Investor Conferences - Business Wire

Mar 04, 2025
pulisher
Mar 04, 2025

AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - Asianet Newsable

Mar 04, 2025
pulisher
Mar 03, 2025

PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz? - Asianet Newsable

Mar 03, 2025
pulisher
Mar 03, 2025

PepGen (PEPG) to Release Quarterly Earnings on Wednesday - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Q1 Earnings Estimate for PepGen Issued By HC Wainwright - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Q1 Earnings Forecast for PepGen Issued By Leerink Partnrs - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

PepGen Inc. (NASDAQ:PEPG) Stock Analysis: Earnings Estimates, Analyst Ratings, and Market Performance - HPBL

Feb 28, 2025
pulisher
Feb 28, 2025

What is HC Wainwright’s Estimate for PepGen FY2025 Earnings? - Defense World

Feb 28, 2025
pulisher
Feb 28, 2025

PepGen (PEPG) Shares Rally In Extended Session - Stocks Telegraph

Feb 28, 2025
pulisher
Feb 28, 2025

Wedbush Weighs in on PepGen’s Q1 Earnings (NASDAQ:PEPG) - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

HC Wainwright Reiterates Buy Rating for PepGen (NASDAQ:PEPG) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Stock market news: Binah Capital Group +184.15%, PepGen +35.25% among top gainers during midday trading - Business Upturn

Feb 27, 2025
pulisher
Feb 27, 2025

Promising Prospects for PepGen Inc.: Buy Rating Affirmed Amid Positive DM1 Treatment Developments - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

What is HC Wainwright’s Estimate for PepGen Q1 Earnings? - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

PepGen CFO Noel Donnelly sells $2,565 in stock By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

PepGen general counsel DeLena sells $2,405 in stock - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

PepGen general counsel DeLena sells $2,405 in stock By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

PepGen CFO Noel Donnelly sells $2,565 in stock - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 26, 2025

Pepgen Inc Azioni (PEPG) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):